PerkinElmer Signals™ Translational: All is FAIR in Biomarker Discovery and Patient Stratification
Introduction
Successful Clinical Outcomes start with unlocking your Biomarker Data.
Learn how PerkinElmer Signals™ Translational has helped Bristol Myers Squibb (BMS) with biomarker discovery and patient stratification whilst keeping the focus on F.A.I.R guidelines (Findable, Accessible, Interoperable, Reusable).
Watch this on-demand webinar to see how PerkinElme Signals™ Translational can support your biomarker projects via:
Seamless data preparation and access for cross-study analysis
Search and aggregate study data(s) on the fly to create ad-hoc cohorts
Fully Integrated Translational Analytics (Powered by TIBCO Spotfire®)
A collaborative framework for effective sharing of data, analytics and your biomarker driven insights
Like what you're reading?
To view the full content, please fill out this form:
